Skip to main content

Candel Therapeutics, Inc 10-Q for FY2025 Q2

Candel Therapeutics, Inc. (CADL)

10-Q 2025-08-14 For: 2025-06-30
View Original
Added on April 10, 2026

About this 10-Q

Candel Therapeutics, Inc filed this 10-Q on August 14, 2025, covering the quarter ended June 30, 2025 (FY2025 Q2).

Headline figures

Quarter ended June 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Net loss
$4.8M
compared with a net loss of $22.24M a year earlier
Diluted EPS
-$0.09
compared with -$0.74 a year earlier